[Federal Register Volume 77, Number 246 (Friday, December 21, 2012)]
[Notices]
[Page 75671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-30785]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Rhodes Technologies

    By Notice dated May 31, 2012, and published in the Federal Register 
on June 8, 2012, 77 FR 34072, Rhodes Technologies, 498 Washington 
Street, Coventry, Rhode Island 02816, made application to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of morphine (9300), a basic class of controlled substance 
listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for conversion and sale to dosage form manufacturers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Rhodes Technologies to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Rhodes Technologies to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems; verification of the company's compliance 
with state and local laws; and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.

    Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-30785 Filed 12-20-12; 8:45 am]
BILLING CODE 4410-09-P